Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

NCT00673777 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: URLC10, VEGFR1 and VEGFR2

Sponsor

Tokyo University

Collaborators

[object Object]